DGCR2 targeting affibody molecules for delivery of drugs and imaging reagents to human beta cells
Sign Up to like & getrecommendations! Published in 2025 at "Scientific Reports"
DOI: 10.1038/s41598-024-84574-y
Abstract: A distinctive feature of both type 1 and type 2 diabetes is the waning of insulin-secreting beta cells in the pancreas. New methods for direct and specific targeting of the beta cells could provide platforms… read more here.
Keywords: affibody; delivery; imaging reagents; beta ... See more keywords